Philippine Standard Time
Saturday, January 18, 2020
Evidence reviewed shows confirmation of high diagnostic accuracy and improved patient outcomes for the Xpert MTB/RIF assay (approved by WHO in 2010) as the initial test to diagnose pulmonary TB (i.e. replacing smear microscopy).
Google Play Store: http://bit.ly/2Foeq8g
Apple Store: https://apple.co/2Fn7h8i
Demo Video: http://bit.ly/306WoRH
Discover current statistics and trends, compare countries and regions, and have global TB data right at your fingertips. The free app works offline so you always have access to the data you need.
For additional Philippines data, you may use the "Race to End TB" mobile apps and web dashboard.
Race-to-end-TB dashboard: http://bit.ly/2kZjmtw
Google Play Store: http://bit.ly/2mmsqci
Apple Store: https://apple.co/2mrMU3r
GDF Catalogue: http://bit.ly/2FtY2mQ
Paper on IGRA: http://bit.ly/2tB8xC9
The Global Drug Facility (GDF) has added an IGRA (interferon-gamma release assay) test for latent TB infection to its catalog. The products required to run the QuantiFERON-TB Gold Plus (QFT-Plus) IGRA are now available at a GDF-negotiated price of $15.90 per test. This price is offered to any public sector or not-for-profit buyer in low- and middle-income countries when procuring through GDF.
IGRA provides an alternative to the Tuberculin Skin Test (TST) which is one of the oldest medical tests still in use and many are advocating for an updated option (see the paper The Case for Retiring the Tuberculin Skin Test at the link above). Costs for testing and treating TB infection continue to come down and better and safer treatment options are increasingly available. Removing TB at the infection stage and avoiding the risk of developing TB disease is becoming a more attractive option for ending TB.
The National TB Control Program, organized in 1978 and operating within a devolved health care delivery system, is one of the public health programs being managed and coordinated by the Infectious Diseases for Prevention and Control Division (IDPCD) of the Disease Prevention and Control Bureau (DPCB) of the Department of Health (DOH).
Write-up: The 2017 Kochon Prize recognizes and pays tribute to the people and organizations who dare to push the scientific boundaries and reach for the targets set forth in the Global Plan to End TB and the End TB Strategy.
Although significant progress has been made to eliminate TB as a public health burden, TB remains one of the leading causes of morbidity and mortality from an infectious disease.
The Philippines National Tuberculosis Program (NTP), with the support of TREAT TB, is conducting an assessment of the NTP's Supervision, Monitoring, and Evaluation system (SME system), particularly as it relates to Programmatic Management of Drug-Resistant TB (PMDT).
The National TB Control Program conducted its first National Consultative Planning (NCP) last February 7-10, 2017 at Bali Village Hotel Resort and Kubo Spa, Tagaytay City.
Philippine Business for Social Progress (PBSP) takes the lead in organizing the five batches of the PMDT Data Quality Check and Plan Enhancement Workshop which ran from January 16 to February 2, 2017.
The Netherlands Ministry of Foreign Affairs Project entitled: “Making the Global Fund Money Work” was launched in the Philippines last January 12-13, 2017 at Pan Pacific Hotel, Malate Manila.